Found 3 hits for monomerid = 50230530 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Matrix metalloproteinase-9
(Homo sapiens (Human)) | BDBM50230530
((S)-2-(benzylamino)-N-hydroxy-3-(N-(4-(p-tolyloxy)...)Show SMILES Cc1ccc(Oc2ccc(cc2)N(C[C@H](NCc2ccccc2)C(=O)NO)S(C)(=O)=O)cc1 Show InChI InChI=1S/C24H27N3O5S/c1-18-8-12-21(13-9-18)32-22-14-10-20(11-15-22)27(33(2,30)31)17-23(24(28)26-29)25-16-19-6-4-3-5-7-19/h3-15,23,25,29H,16-17H2,1-2H3,(H,26,28)/t23-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 7.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
| Assay Description Inhibition of MMP9 |
Bioorg Med Chem Lett 18: 1140-5 (2008)
Article DOI: 10.1016/j.bmcl.2007.11.129 BindingDB Entry DOI: 10.7270/Q2BP02JM |
More data for this Ligand-Target Pair | |
72 kDa type IV collagenase
(Homo sapiens (Human)) | BDBM50230530
((S)-2-(benzylamino)-N-hydroxy-3-(N-(4-(p-tolyloxy)...)Show SMILES Cc1ccc(Oc2ccc(cc2)N(C[C@H](NCc2ccccc2)C(=O)NO)S(C)(=O)=O)cc1 Show InChI InChI=1S/C24H27N3O5S/c1-18-8-12-21(13-9-18)32-22-14-10-20(11-15-22)27(33(2,30)31)17-23(24(28)26-29)25-16-19-6-4-3-5-7-19/h3-15,23,25,29H,16-17H2,1-2H3,(H,26,28)/t23-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 202 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
| Assay Description Inhibition of MMP2 |
Bioorg Med Chem Lett 18: 1140-5 (2008)
Article DOI: 10.1016/j.bmcl.2007.11.129 BindingDB Entry DOI: 10.7270/Q2BP02JM |
More data for this Ligand-Target Pair | |
Interstitial collagenase
(Homo sapiens (Human)) | BDBM50230530
((S)-2-(benzylamino)-N-hydroxy-3-(N-(4-(p-tolyloxy)...)Show SMILES Cc1ccc(Oc2ccc(cc2)N(C[C@H](NCc2ccccc2)C(=O)NO)S(C)(=O)=O)cc1 Show InChI InChI=1S/C24H27N3O5S/c1-18-8-12-21(13-9-18)32-22-14-10-20(11-15-22)27(33(2,30)31)17-23(24(28)26-29)25-16-19-6-4-3-5-7-19/h3-15,23,25,29H,16-17H2,1-2H3,(H,26,28)/t23-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
| Assay Description Inhibition of MMP1 |
Bioorg Med Chem Lett 18: 1140-5 (2008)
Article DOI: 10.1016/j.bmcl.2007.11.129 BindingDB Entry DOI: 10.7270/Q2BP02JM |
More data for this Ligand-Target Pair | |